Abstract
Diabetes mellitus is an important chronic disease with a growing prevalence that absorbs an ever increasing investment of resources. This population-based study evaluated the direct medical costs of diabetes mellitus in an HMO setting. We evaluated both the total cost of diabetic patients and their added cost in comparison to other HMO members (diabetes-related costs). Data were obtained for the years 1999–2001 in a cohort of 24,632 diabetic patients followed up for 3 years drawn from the computerized medical administrative database of a large HMO in Israel, insuring around 25% of the population . The mean direct cost of the medical treatment of a diabetic patient rose 29% from US $2,017 in 1999 to $2,601 in 2001 (in 2001 terms) in comparison to a 19.7% rise (from $1,246 to $1,492). Hospitalizations, medication, and physician visits account for 39%, 29%, and 21% of the total diabetic patient costs, respectively. Dialysis, insulin intake, impaired creatinine, and elevated HbA1c were associated with increased expenditures. According to our results, the total national medical cost of diabetes alone in 2001 was $317 million and that of diabetic patients was $564 million, 6.9% and 12.4% of the total Israeli HMO budget, respectively. The study presents the use of a population-based computerized database to comprehensively assess the economic burden of disease and the potential savings from prevention. The study data suggest a rise in the cost of diabetes which has implications for prevention and treatment policies.
Similar content being viewed by others
References
King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431
Control ICfD (1999) Health status in Israel 1999. Ministry of Health: Tel-Hashomer
Rubin RJ, Altman WM, Mendelson DN (1994) Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78:809A–809F
Brown M (1990) The national economic burden of cancer: an update. J Natl Cancer Inst 82:1811–1814
Laing W, Williams R (1989) Diabetes: a model for health care management. Office of Health Economics: London
Gruber W, Lander T, Leese B, Songer T, Williams R (1998) The economics of diabetes and diabetes care. International Diabetes Federation: Brussels
American Diabetes Association (1998) Economic consequence of diabetes mellitus in the U.S. in 1997. Diabetes Care 21:296–309
Williams R, Van Gaal L, Lucioni C (2002) Assessing the impact of complications on the costs of type II diabetes. Diabetologia 45:S13–S17
Massi-Benedetti M (2002) The cost of diabetes type II in Europe: the CODE-2 study. Diabetologia 45:S1–S4
Israel Center for Disease Control (2004) Health status of Israel 2003. Israel Ministry of Health: Jerusalem
Songer T (1998) Studies on the cost of diabetes. Centers for Disease Control and Prevention: Atlanta
Stern E, Benbassat CA, Nahshoni A, Blum I (2001) Hospitalization for general medical conditions among diabetic patients in Israel. Isr Med Assoc J 3:21–23
Jonsson B (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45:S5–S12
Israel IDDM Registry Study Group (2000) Incidence of insulin dependent diabetes in youth in Israel. Harefuah 138:290–294
Kenny SJ, Aubert RE, Geiss LS (1995) Prevalence and incidence of non-insulin-dependent diabetes. In: Diabetes in America, 2nd edn. National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda
Mustard CA, Kaufert P, Kozyrskyj A, Mayer T (1998) Sex differences in the use of health care services. N Engl J Med 4:338
Mathiesen ER, Hommel E, Giese J, Parving HH (1991) Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81–87
Conflict of interest:
No information supplied
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chodick, G., Heymann, A.D., Wood, F. et al. The direct medical cost of diabetes in Israel. Eur J Health Econ 6, 166–171 (2005). https://doi.org/10.1007/s10198-004-0269-7
Issue Date:
DOI: https://doi.org/10.1007/s10198-004-0269-7